Linda Sugar

Author PubWeight™ 34.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther 2007 2.97
2 Prospective multi-institutional study evaluating the performance of prostate cancer risk calculators. J Clin Oncol 2011 2.21
3 Assessing individual risk for prostate cancer. J Clin Oncol 2007 2.13
4 Utility of serum tumor markers during surveillance for stage I seminoma. Cancer 2012 2.05
5 A novel serum marker, total prostate secretory protein of 94 amino acids, improves prostate cancer detection and helps identify high grade cancers at diagnosis. J Urol 2006 1.71
6 Utility of incorporating genetic variants for the early detection of prostate cancer. Clin Cancer Res 2009 1.39
7 The clinical utility of miR-21 as a diagnostic and prognostic marker for renal cell carcinoma. J Mol Diagn 2012 1.24
8 Protein-coding and microRNA biomarkers of recurrence of prostate cancer following radical prostatectomy. Am J Pathol 2011 1.24
9 A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance. J Magn Reson Imaging 2014 1.21
10 MR imaging-controlled transurethral ultrasound therapy for conformal treatment of prostate tissue: initial feasibility in humans. Radiology 2012 1.13
11 MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology 2010 1.12
12 Analysis of the spatial and temporal accuracy of heating in the prostate gland using transurethral ultrasound therapy and active MR temperature feedback. Phys Med Biol 2009 1.07
13 The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res 2005 1.02
14 miR-221 Is down-regulated in TMPRSS2:ERG fusion-positive prostate cancer. Anticancer Res 2011 0.99
15 New variants at 10q26 and 15q21 are associated with aggressive prostate cancer in a genome-wide association study from a prostate biopsy screening cohort. Cancer Biol Ther 2011 0.98
16 Variants of the hK2 protein gene (KLK2) are associated with serum hK2 levels and predict the presence of prostate cancer at biopsy. Clin Cancer Res 2006 0.98
17 Protective effect of metformin in CD1 mice placed on a high carbohydrate-high fat diet. Biochem Biophys Res Commun 2010 0.95
18 Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs. Biol Chem 2010 0.94
19 Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy. J Urol 2007 0.89
20 Xanthogranulomatous cystitis associated with inflammatory bowel disease. Can Urol Assoc J 2010 0.85
21 MicroRNA detection in prostate tumors by quantitative real-time PCR (qPCR). J Vis Exp 2012 0.82
22 Nomogram prediction for prostate cancer and aggressive prostate cancer at time of biopsy: utilizing all risk factors and tumor markers for prostate cancer. Can J Urol 2006 0.81
23 Making sense of prostate specific antigen: improving its predictive value in patients undergoing prostate biopsy. J Urol 2006 0.80
24 Canadian Consensus Conference: The FDA decision on the use of 5ARIs. Can Urol Assoc J 2012 0.80
25 Variation in patterns of practice in diagnosing screen-detected prostate cancer. BJU Int 2004 0.79
26 Whole-transcriptome analysis reveals established and novel associations with TMPRSS2:ERG fusion in prostate cancer. Anticancer Res 2012 0.78
27 Capsaicin: a novel radio-sensitizing agent for prostate cancer. Prostate 2014 0.77
28 Prostate cancer pathology audits: is central pathology review still warranted? Can J Urol 2012 0.77
29 Feasibility and safety of silicone rubber contrast-enhanced microcomputed tomography in evaluating the angioarchitecture of prostatectomy specimens. Transl Oncol 2011 0.75
30 Clinical significance of biopsy-derived primary Gleason score among radical prostatectomy candidates with Gleason 7 tumors. Urology 2002 0.75
31 Exercise does not counteract the effects of a "westernized" diet on prostate cancer xenografts. Prostate 2013 0.75